Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
Condition: Multiple Sclerosis Interventions: Drug: IMU-838; Drug: Placebo matching IMU-838 Sponsor: Immunic AG Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials